Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Damilola Gibson"'
Autor:
Peter M. Voorhees, Frits van Rhee, Luis Fayad, Damilola Gibson, Karan Kanhai, Razelle Kurzrock, Corey Casper
Publikováno v:
The Lancet. Haematology. 7(3)
Background Siltuximab is recommended by international consensus as a first-line treatment for idiopathic multicentric Castleman disease on the basis of durable efficacy and safety data. This study was done to assess the long-term safety and activity
Autor:
Damilola Gibson, Robert J. Motzer, Camillo Porta, Jonathan Belsey, Bernard Escudier, Jonathan Morgan, Tim Eisen
Publikováno v:
Expert review of anticancer therapy. 18(11)
The efficacy of VEGF-targeting therapies in clinical trials led to their recommendation in clinical guidelines for use across the advanced or metastatic renal cell carcinoma (RCC) treatment landscape, however, tolerability (including off-target effec
Autor:
Johnson S. Khor, Corey Casper, Sheila K Pierson, Katherine Floess, Gordan Srkalovic, Eric Haljasmaa, Amy Y. Liu, Amy Chadburn, Karan Kanhai, Yue Ren, Jasira Ziglar, Megan S. Lim, Rabecka Martin, Faizaan Akhter, Hongzhe Lee, Elaine S. Jaffe, Erin NaPier, Damilola Gibson, David C. Fajgenbaum, Thomas S. Uldrick, Frits van Rhee
Publikováno v:
Blood. 134:1540-1540
Background Human herpes-virus 8-negative/idiopathic multicentric Castleman disease (iMCD) is a rare inflammatory disorder involving multicentric lymphadenopathy with characteristic histopathology. Clinical presentation is heterogenous and includes cy